wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34077853-2EDE4290-7E03-4A8D-9A71-D5A78CB5D300
Q34077853-2EDE4290-7E03-4A8D-9A71-D5A78CB5D300
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34077853-2EDE4290-7E03-4A8D-9A71-D5A78CB5D300
A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer.
P2860
Q34077853-2EDE4290-7E03-4A8D-9A71-D5A78CB5D300
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34077853-2EDE4290-7E03-4A8D-9A71-D5A78CB5D300
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
475af6a87ba81e065c2890cbe27aac37fa520641
P2860
Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.